Skip to main content
# Title Department Research Year
61 Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties 2022
62 Exploration of components contributing to potent cytotoxicity of Gardenia thunbergia L. f. against human leukemia and hepatoma Department of Pharmacognosy 2022
63 Design-of-experiment approach to quantify the effect of nano-sized silica on tableting properties of microcrystalline cellulose to facilitate direct compression tableting of binary blend containing a low-dose drug Department of Industrial Pharmacy 2022
64 Evaluation of Different Surface Coating Agents for Selenium Nanoparticles: Enhanced Anti-Inflammatory Activity and Drug Loading Capacity Department of Pharmaceutics 2022
65 Development of magnetic molecularly imprinted polymers for the extraction of salivary pepsin prior to analysis by a novel HPLC-SEC method Department of Pharmaceutical Analytical Chemistry 2022
66 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Pharmaceutics 2022
67 Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity Department of Pharmaceutical Organic Chemistry 2022
68 EVALUATION OF RHEUM PALMATUM RHIZOMES AVAILABLE IN JORDANIAN MARKETS AND INVESTIGATION OF ITS POTENTIAL USE AS HAIR DYE COSMETICS 2022
69 New Cell Cycle Checkpoint Pathways Regulators with 2-Oxo-indoline Scaffold as Potential Anticancer Agents: Design, Synthesis, Biological Activities and In Silico Studies Department of Medicinal Chemistry 2022
70 Design, synthesis, crystal structures and biological evaluation of some 1, 3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects 2022